Fingerprint
Dive into the research topics of 'Phase II trial to assess the biochemical efficacy of transgenic alpha1-anti-trypsin as an effective treatment of cystic fibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial to assess the biochemical efficacy of transgenic alpha1-anti-trypsin as an effective treatment of cystic fibrosis
L. Martin*, D. Downey, J. S. Elborn, D. Bilton, M. T. Keogan, J. Edgar
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)